18 results
S-8
EX-99.1
NAMS
NewAmsterdam Pharma Company N.V.
3 Jul 24
Registration of securities for employees
4:34pm
, as amended, and the regulations and guidance issued thereunder.
“Disability” means the inability of a U.S. Participant to engage in any substantial gainful … (except in the event of the U.S. Participant’s Disability, in which case a 12-month period applies or in the event of the U.S. Participant’s death
S-8
EX-99.2
NAMS
NewAmsterdam Pharma Company N.V.
3 Jul 24
Registration of securities for employees
4:34pm
.
“Disability” means the inability of a U.S. Participant to engage in any substantial gainful activity by reason of any medically determinable physical
DEF 14A
NAMS
NewAmsterdam Pharma Company N.V.
9 May 24
Definitive proxy
4:15pm
that exercisability is extended in the case of death or disability. In the event of a change of control, the Compensation Committee will determine … without regard to race, color, religion, sex, ancestry, national origin or disability. The Nomination and Corporate Governance Committee does not have
PRE 14A
5hwiz7
29 Apr 24
Preliminary proxy
5:00pm
10-K
EX-10.7
yms b851yldptlnbdx3q
28 Feb 24
Annual report
8:00am
10-K
EX-10.9
9vc ppi4p0
28 Feb 24
Annual report
8:00am
10-K
EX-10.10
fupceq2 n1tn
28 Feb 24
Annual report
8:00am
10-K
EX-10.4
70p8e ds0osa
28 Feb 24
Annual report
8:00am
10-K
kq782m 34dvc3
28 Feb 24
Annual report
8:00am
S-8
EX-99.1
5j3io
31 Mar 23
Registration of securities for employees
7:36am
S-8
EX-99.2
3tkxu0210q8hw144n
31 Mar 23
Registration of securities for employees
7:36am
F-1
EX-10.13
62nvoq10gf2e f4d33vb
19 Dec 22
Registration statement (foreign)
6:22pm
F-1
EX-10.15
o8iov
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
EX-10.1
gxzoyx846ejf55
19 Dec 22
NewAmsterdam Announces Appointment of David Topper as Chief Financial Officer
4:23pm
6-K
EX-2.1
lk8cxebo0g 8wdpe9
23 Nov 22
Current report (foreign)
4:36pm
F-4/A
EX-10.13
n65sx0joylk 7g
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
- Prev
- 1
- Next